Iveric Bio Inc (ISEE)
is trading 10% higher at $19.525 today. While it's a mildly positive day for the Health Care sector in general, the stock is rapidly outshining it's peers.
-IVERIC bio reports positive results from the phase III GATHER2 study
-The study was evaluating Zimura, an investigational candidate, for the treatment of geographic atrophy
-Investors are applauding the company's late-stage clinical results
Iveric Bio Inc has been trading between a 52-week high of $19.68 and a 52-week low of $8.85. The stock has a market cap of $2.31 Billion.
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:
Bdonn_88 - 2 upvotes - source
Gonna watch my $iSee calls print tomorrow. HOLY FUCK! Lol 👀
jobmarketsucks - 2 upvotes - source
ISEE It has gone from like $9 to almost $20 in two days. Edit: My mistake was buying the puts at $15.
Bdonn_88 - 1 upvotes - source
Anyone watching $isee ? 👀shits been wild this week
jobmarketsucks - 1 upvotes - source
Thermophoresis - 1 upvotes - source
Is it too late for DOCU calls? Maybe ISEE puts? some lotto calls for SPY and QQQ? Flip a coin for Cnotes in the parking?
Bobodelboy - 0 upvotes - source
Someone mentioned the volume of ISEE the other day and now it’s over 100 million. Get in there while you can